Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 3
1993 2
2003 1
2004 1
2005 2
2006 4
2007 1
2008 1
2010 1
2011 2
2012 4
2013 2
2014 4
2015 3
2016 5
2017 9
2018 4
2019 8
2020 12
2021 12
2022 16
2023 11
2024 12
2025 12
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for E. ghaderi
Your search for E. Gaderi retrieved no results
Expression of Concern.
[No authors listed] [No authors listed] Addict Biol. 2024 Sep;29(9):e13437. doi: 10.1111/adb.13437. Addict Biol. 2024. PMID: 40179057 Free PMC article.
A. Ghaderi, H.R. Banafshe, N. Mirhosseini, M, Motmaen, F. Mehrzad, F. Bahmani, E. Aghadavod, M.A. ...
A. Ghaderi, H.R. Banafshe, N. Mirhosseini, M, Motmaen, F. Mehrzad, F. Bahmani, E. Aghadavod, M.A. ...
Fingerprints, Pharmaceutical and Radical Scavenging Activity Evaluation of an Alzheimer-Targeted Herbal Preparation.
Dabaghian F, Khademian S, Azadi A, Zarshenas M. Dabaghian F, et al. Iran J Med Sci. 2016 May;41(3 Suppl):S6. Iran J Med Sci. 2016. PMID: 27840472 Free PMC article.
METHODS: By searching through the traditional pharmaceutical manuscripts such as Qarabadeen-e-Salehi, Qarabadeen-e-Azam, Qarabadeen-e-Ghaderi and Canon of Medicine, a simple but proven compound remedy (frankincense and black pepper) was selected. ...
METHODS: By searching through the traditional pharmaceutical manuscripts such as Qarabadeen-e-Salehi, Qarabadeen-e-Azam, Qarab …
Targeted and epigenetic therapies for acute myeloid leukemia treatment.
Shokoohi M, Ghaderi M, Mokarami M, Arian H, Mohammadnabi S, Farokhi A. Shokoohi M, et al. Discov Oncol. 2025 Sep 26;16(1):1711. doi: 10.1007/s12672-025-03534-8. Discov Oncol. 2025. PMID: 41003912 Free PMC article. Review.
The article reviews key targeted therapies, including IDH inhibitors (e.g., ivosidenib, enasidenib) for IDH mutations, FLT3 inhibitors (e.g., midostaurin, gilteritinib) for FLT3 alterations, BCL2 inhibitors (e.g., venetoclax) impacting apoptosis, and emerging …
The article reviews key targeted therapies, including IDH inhibitors (e.g., ivosidenib, enasidenib) for IDH mutations, FLT3 inhibitor …
A multicenter evaluation of a novel microfluidic rapid AST assay for Gram-negative bloodstream infections.
Berinson B, Davies E, Torpner J, Flinkfeldt L, Fernberg J, Åman A, Bergqvist J, Öhrn H, Ångström J, Johansson C, Jäder K, Andersson H, Ghaderi E, Rolf M, Sundqvist M, Rohde H, Fernandez-Zafra T, Malmberg C. Berinson B, et al. J Clin Microbiol. 2024 Oct 16;62(10):e0045824. doi: 10.1128/jcm.00458-24. Epub 2024 Sep 26. J Clin Microbiol. 2024. PMID: 39324811 Free PMC article.
MicroRNAs and exosomes: key players in HIV pathogenesis.
Sadri Nahand J, Bokharaei-Salim F, Karimzadeh M, Moghoofei M, Karampoor S, Mirzaei HR, Tabibzadeh A, Jafari A, Ghaderi A, Asemi Z, Mirzaei H, Hamblin MR. Sadri Nahand J, et al. HIV Med. 2020 Apr;21(4):246-278. doi: 10.1111/hiv.12822. Epub 2019 Nov 22. HIV Med. 2020. PMID: 31756034 Free PMC article. Review.
These nanovehicles target their cargos (i.e. DNA, RNA, viral proteins and miRNAs) leading to alteration of the behaviour of recipient cells. ...
These nanovehicles target their cargos (i.e. DNA, RNA, viral proteins and miRNAs) leading to alteration of the behaviour of recipient …
Behavioural components and delivery features of early childhood obesity prevention interventions: intervention coding of studies in the TOPCHILD Collaboration systematic review.
Johnson BJ, Chadwick PM, Pryde S, Seidler AL, Hunter KE, Aberoumand M, Williams JG, Lau HI, Libesman S, Aagerup J, Barba A, Baur LA, Morgillo S, Sanders L, Taki S, Hesketh KD, Campbell K, Manson A, Hayes A, Webster A, Wood C, O'Connor DA, Matvienko-Sikar K, Robledo K, Askie L, Wolfenden L, Taylor R, Yin HS, Brown V, Fiks A, Ventura A, Ghaderi A, Taylor BJ, Stough C, Helle C, Palacios C, Perrin EM, Reifsnider E, Rasmussen F, Paul IM, Savage JS, Thomson J, Banna J, Larsen J, Joshipura K, Ong KK, Karssen L, Wen LM, Vitolo M, Røed M, Bryant M, Rivera MC, Messito MJ, Golova N, Øverby NC, Gross R, Lakshman R, Byrne R, Rothman RL, O'Reilly S, Anzman-Frasca S, Verbestel V, Maffeis C, de la Haye K, Salvy SJ, Mihrshahi S, Ramachandran J, Baratto PS, Golley RK; TOPCHILD Collaboration. Johnson BJ, et al. Int J Behav Nutr Phys Act. 2025 Feb 5;22(1):14. doi: 10.1186/s12966-025-01708-9. Int J Behav Nutr Phys Act. 2025. PMID: 39910407 Free PMC article.
BACKGROUND: Early childhood obesity prevention interventions that aim to change parent/caregiver practices related to infant (milk) feeding, food provision and parent feeding, movement (including activity, sedentary behaviour) and/or sleep health (i.e. target parental beha …
BACKGROUND: Early childhood obesity prevention interventions that aim to change parent/caregiver practices related to infant (milk) feeding, …
Immunological and biological dissection of normal and tumoral salivary glands.
Haghshenas MR, Ghaderi H, Daneste H, Ghaderi A. Haghshenas MR, et al. Int Rev Immunol. 2023;42(2):139-155. doi: 10.1080/08830185.2021.1958806. Epub 2021 Aug 11. Int Rev Immunol. 2023. PMID: 34378486 Review.
Immune responses may directly play a limiting role in tumor growth and expansion, or may participate in formation of a rich milieu for tumor growth in cooperation with other cellular and regulatory molecules. Immune checkpoint molecules (e.g. PDLs, HLA-G and LAG3) are freq …
Immune responses may directly play a limiting role in tumor growth and expansion, or may participate in formation of a rich milieu for tumor …
Detecting somatic variants in purified brain DNA obtained from surgically implanted depth electrodes in epilepsy.
Mascarenhas R, Merrikh D, Khanbabaei M, Kaur N, Ghaderi N, Maroilley T, Liu Y, Soule T, Appendino JP, Jacobs J, Wiebe S; Calgary Comprehensive Epilepsy Program Collaborators; Hader W, Pfeffer G, Tarailo-Graovac M, Klein KM. Mascarenhas R, et al. Epilepsia. 2025 Apr;66(4):1234-1249. doi: 10.1111/epi.18251. Epub 2025 Jan 3. Epilepsia. 2025. PMID: 39751777 Free PMC article.
OBJECTIVE: Somatic variants causing epilepsy are challenging to detect, as they are only present in a subset of brain cells (e.g., mosaic), resulting in low variant allele frequencies. Traditional methods relying on surgically resected brain tissue are limited to patients …
OBJECTIVE: Somatic variants causing epilepsy are challenging to detect, as they are only present in a subset of brain cells (e.g., mo …
Comparison of three doses of amikacin on alternate days with a daily dose of meropenem during the same period for the treatment of urinary tract infection with E. coli: a double-blind clinical trial.
Mohsenpour B, Ahmadi A, Azizzadeh H, Ghaderi E, Hajibagheri K, Afrasiabian S, Lotfi G, Farzinpoor Z. Mohsenpour B, et al. BMC Res Notes. 2024 Jan 25;17(1):38. doi: 10.1186/s13104-023-06654-y. BMC Res Notes. 2024. PMID: 38273327 Free PMC article. Clinical Trial.
This study compares three doses of amikacin on alternate days with a daily dose of meropenem in the same period for the treatment of UTIs with E. coli in a double-blind clinical trial. METHODS: The current double-blind clinical trial compares three doses of amikacin on alt …
This study compares three doses of amikacin on alternate days with a daily dose of meropenem in the same period for the treatment of UTIs wi …
116 results